(Q33745342)

29 July 2017

Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes (English)

1 reference

29 July 2017

1 reference

6

Benedetto Vitiello

1 reference

29 July 2017

9

Graham J Emslie

1 reference

29 July 2017

1

Betsy D Kennard

1 reference

29 July 2017

Susan G Silva

2

1 reference

29 July 2017

Simon Tonev

3

1 reference

29 July 2017

Paul Rohde

4

1 reference

29 July 2017

Jennifer L Hughes

5

1 reference

29 July 2017

Christopher J Kratochvil

7

1 reference

29 July 2017

John F Curry

8

1 reference

29 July 2017

Mark Reinecke

10

1 reference

29 July 2017

John March

11

1 reference

29 July 2017

1 February 2009

1 reference

Journal of the American Academy of Child and Adolescent Psychiatry

29 July 2017

1 reference

29 July 2017

48

1 reference

29 July 2017

2

1 reference

29 July 2017

186-195

1 reference

Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Report by the ACNP Task Force on response and remission in major depressive disorder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Review of the efficacy and safety of antidepressants in youth depression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Prevention of relapse following cognitive therapy vs medications in moderate to severe depression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Remission versus response: the new gold standard of antidepressant care.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Sertraline versus imipramine to prevent relapse in chronic depression.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Clinical guidelines for depressive disorders in childhood and adolescence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Clinical implications of "subthreshold" depressive symptoms

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Partial remission in depressive disorders.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Presentation and course of major depressive disorder during childhood and later years of the life span

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Depressive relapses and incomplete recovery from index episode

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Subthreshold depression in adolescence and mental health outcomes in adulthood.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Treatment for Adolescents With Depression Study (TADS): Rationale, Design, and Methods

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Community clinic treatment of depressed youth: benchmarking usual care against CBT clinical trials.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Maintenance therapy for chronic depression. A controlled clinical trial of desipramine.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843506

Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder

30 October 2018

1 reference

12 December 2020

Subsyndromal depression in adolescents after a brief psychotherapy trial: course and outcome

1 reference

12 December 2020

Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year

1 reference

12 December 2020

Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment

1 reference

12 December 2020

Cognitive behavioral treatment of residual symptoms in primary major depressive disorder

1 reference

12 December 2020

Residual symptoms after partial remission: an important outcome in depression

1 reference

12 December 2020

First-episode major depressive and dysthymic disorder in childhood: clinical and sociodemographic factors in recovery

1 reference

12 December 2020

Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. AACAP

1 reference

12 December 2020

Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions

1 reference

12 December 2020

Glad for what TADS adds, but many TADS grads still sad

1 reference

12 December 2020

10.1097/CHI.0B013E31819176F9

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference